JNJ
JNJ
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

Johnson & Johnson

S&P 500 Dow Jones Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$269.99
-0.23 (-0.09%)
As of Sep 20, 9:30 PM ET ·
Financial Highlights (FY 2026)
Revenue
92.50B
Net Income
26.32B
Gross Margin
68.0%
Profit Margin
28.5%
Rev Growth
+5.6%
D/E Ratio
0.59
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 68.0% 68.0% 44.0% 44.0%
Operating Margin 34.6% 31.1% 29.5% 29.2%
Profit Margin 28.5% 27.0% 19.9% 21.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 92.50B 87.59B 81.19B 89.13B
Gross Profit 62.88B 59.55B 35.72B 39.21B
Operating Income 32.00B 27.27B 23.92B 26.00B
Net Income 26.32B 22.43B 16.19B 19.43B
Gross Margin 68.0% 68.0% 44.0% 44.0%
Operating Margin 34.6% 31.1% 29.5% 29.2%
Profit Margin 28.5% 27.0% 19.9% 21.8%
Rev Growth +5.6% +5.6% +12.0% -8.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 119.23B 119.23B 181.05B 177.00B
Total Equity 202.83B 202.83B 426.62B 418.52B
D/E Ratio 0.59 0.59 0.42 0.42
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 39.36B 35.41B 32.24B 37.61B
Free Cash Flow — — 20.95B 18.85B